• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors.

作者信息

Kanamori Masayuki, Kumabe Toshihiro, Sonoda Yukihiko, Nishino Yoshikazu, Watanabe Mika, Tominaga Teiji

机构信息

Department of Neurosurgery, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.

出版信息

J Neurooncol. 2009 Jun;93(2):219-28. doi: 10.1007/s11060-008-9762-7. Epub 2008 Dec 20.

DOI:10.1007/s11060-008-9762-7
PMID:19099201
Abstract

The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O(6)-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index > or = 25%, diffuse expression of nestin, and p53 labeling index > or = 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index > or = 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.

摘要

相似文献

1
Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors.
J Neurooncol. 2009 Jun;93(2):219-28. doi: 10.1007/s11060-008-9762-7. Epub 2008 Dec 20.
2
Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.世界卫生组织(WHO)II级和III级弥漫性胶质瘤中1号染色体短臂(1p)和19号染色体长臂(19q)状态与O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)、p53和Ki-67表达的相关性:一项临床病理研究
Neuropathol Appl Neurobiol. 2009 Aug;35(4):367-379. doi: 10.1111/j.1365-2990.2008.01002.x. Epub 2008 Nov 18.
3
Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.并非所有1p/19q未缺失的少突胶质细胞瘤都是星形细胞性的。
Oncotarget. 2016 Oct 4;7(40):64615-64630. doi: 10.18632/oncotarget.11378.
4
Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.1号染色体短臂和19号染色体状态以及p53和p16表达模式作为少突胶质细胞瘤的预后指标:一项使用荧光原位杂交的临床病理研究
Neuropathology. 2007 Feb;27(1):10-20. doi: 10.1111/j.1440-1789.2006.00735.x.
5
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?少突胶质细胞瘤中1p/19q联合缺失:预测性还是预后性生物标志物?
Clin Cancer Res. 2007 Dec 1;13(23):6933-7. doi: 10.1158/1078-0432.CCR-07-0573.
6
Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.染色体 1p/19q 状态结合 p53 蛋白表达可改善少突胶质细胞瘤的诊断和预后评估。
Chin Med J (Engl). 2010 Dec;123(24):3566-73.
7
Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.1p/19q 共缺失型少突胶质细胞瘤经初始化疗治疗后,无论肿瘤级别如何,15 年的存活率为 80%。
J Neurooncol. 2019 Jan;141(1):205-211. doi: 10.1007/s11060-018-03027-5. Epub 2018 Dec 18.
8
Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.1p/19q 共缺失联合影像学特征的区域性特异性对间变性少突胶质细胞瘤患者生存结局的预测。
J Neurooncol. 2018 Feb;136(3):523-531. doi: 10.1007/s11060-017-2673-8. Epub 2017 Dec 11.
9
The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.41例土耳其间变性少突胶质细胞瘤患者中1p/19q共缺失、IDH1突变、p53过表达之间的相关性及其预后作用
Turk Neurosurg. 2017;27(5):682-689. doi: 10.5137/1019-5149.JTN.16832-15.1.
10
[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].[1号和19号染色体杂合性缺失与胶质瘤中MGMT、p53和Ki-67蛋白表达的相关性]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8.

引用本文的文献

1
Distant recurrence in the cerebellar dentate nucleus through the dentato-rubro-thalamo-cortical pathway in supratentorial glioma cases.幕上胶质瘤经齿状核-红核-丘脑-皮质束引起小脑齿状核远隔复发。
Acta Neurochir (Wien). 2024 Feb 14;166(1):83. doi: 10.1007/s00701-024-05981-8.
2
Radiological assessment schedule for 1p/19q-codeleted gliomas during the surveillance period using parametric modeling.使用参数模型对1p/19q共缺失型胶质瘤在监测期进行的放射学评估计划。
Neurooncol Adv. 2021 May 20;3(1):vdab069. doi: 10.1093/noajnl/vdab069. eCollection 2021 Jan-Dec.
3
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.

本文引用的文献

1
Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells.巢蛋白小干扰RNA(siRNA)可降低培养的星形细胞瘤细胞的生长。
Brain Res. 2008 Feb 27;1196:103-12. doi: 10.1016/j.brainres.2007.11.026. Epub 2007 Nov 22.
2
Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.多形性胶质母细胞瘤肿瘤及瘤周区域中的干细胞标志物巢蛋白和c-Jun氨基末端激酶:可能的预后意义
Clin Cancer Res. 2007 Dec 1;13(23):6970-7. doi: 10.1158/1078-0432.CCR-07-1229.
3
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
IDH突变状态与II级和III级星形细胞瘤患者肿瘤相关性癫痫或静脉血栓栓塞之间的关联。
Brain Tumor Pathol. 2021 Jul;38(3):218-227. doi: 10.1007/s10014-021-00406-1. Epub 2021 Jul 16.
4
Incidence of initial spinal metastasis in glioblastoma patients and the importance of spinal screening using MRI.胶质母细胞瘤患者首发脊柱转移的发生率及 MRI 脊柱筛查的重要性。
J Neurooncol. 2019 Jan;141(2):337-345. doi: 10.1007/s11060-018-03036-4. Epub 2018 Nov 9.
5
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.肿瘤周边的胶质瘤细胞具有干细胞表型。
PLoS One. 2016 May 12;11(5):e0155106. doi: 10.1371/journal.pone.0155106. eCollection 2016.
6
Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.巢蛋白表达与胶质瘤患者不良临床病理特征及预后相关:一项关联研究与Meta分析
Mol Neurobiol. 2017 Jan;54(1):727-735. doi: 10.1007/s12035-016-9689-5. Epub 2016 Jan 14.
7
Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.荧光原位杂交技术对少突胶质细胞瘤1p/19q状态的自动化分析:原理及算法建议
PLoS One. 2015 Jul 2;10(7):e0132125. doi: 10.1371/journal.pone.0132125. eCollection 2015.
8
Clinical value of CD133 and nestin in patients with glioma: a population-based study.CD133和巢蛋白在神经胶质瘤患者中的临床价值:一项基于人群的研究。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3739-51. eCollection 2014.
9
ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas.免疫荧光原位杂交技术是评估少突胶质细胞瘤中1p和19q状态的可靠技术。
PLoS One. 2014 Jun 20;9(6):e100342. doi: 10.1371/journal.pone.0100342. eCollection 2014.
10
A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.“加权”荧光原位杂交增强了 1p/19q 缺失代码在纯和混合少突胶质细胞瘤中的有利预后价值。
J Neuropathol Exp Neurol. 2013 May;72(5):432-41. doi: 10.1097/NEN.0b013e3182901f41.
少突胶质细胞瘤中1p/19q联合缺失:预测性还是预后性生物标志物?
Clin Cancer Res. 2007 Dec 1;13(23):6933-7. doi: 10.1158/1078-0432.CCR-07-0573.
4
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.根据分子和表型标准,富含胶质母细胞瘤衍生干细胞的培养物形成不同的亚组。
Oncogene. 2008 May 1;27(20):2897-909. doi: 10.1038/sj.onc.1210949. Epub 2007 Nov 26.
5
Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.神经干细胞标志物巢蛋白和神经胶质蛋白在人类胶质瘤进展中的作用:巢蛋白与患者生存预后的相关性
Surg Neurol. 2007 Aug;68(2):133-43; discussion 143-4. doi: 10.1016/j.surneu.2006.10.050. Epub 2007 May 29.
6
Treatment for posterior fossa dissemination of primary supratentorial glioma.
J Neurosurg. 2007 Apr;106(4):567-74. doi: 10.3171/jns.2007.106.4.567.
7
Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.采用PCV化疗治疗新诊断的有症状的单纯低级别少突胶质细胞瘤。
Eur J Neurol. 2007 Apr;14(4):391-8. doi: 10.1111/j.1468-1331.2007.01675.x.
8
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.间变性和复发性少突胶质细胞瘤中O6-甲基鸟嘌呤DNA甲基转移酶启动子甲基化状态、1p和19q缺失与替莫唑胺反应之间的相关性:一项前瞻性GICNO研究
J Clin Oncol. 2006 Oct 10;24(29):4746-53. doi: 10.1200/JCO.2006.06.3891. Epub 2006 Sep 5.
9
Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.超分割放疗联合多药化疗(丙卡巴肼、阿糖胞苷和长春新碱)治疗高级别胶质瘤:一项前瞻性研究。
Anticancer Res. 2006 May-Jun;26(3B):2457-62.
10
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.辅助性丙卡巴肼、洛莫司汀和长春新碱可改善新诊断的间变性少突胶质细胞瘤和少突星形细胞瘤的无进展生存期,但不能改善总生存期:一项欧洲癌症研究与治疗组织的随机 III 期试验。
J Clin Oncol. 2006 Jun 20;24(18):2715-22. doi: 10.1200/JCO.2005.04.6078.